Citation Impact
Citing Papers
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
2016
Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies
2018
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells
2015
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
2016
Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
2016
ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment
2017
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
2015
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
2015
Breast cancer
2019 Standout
TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
2016
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Cell-free circulating tumor DNA in cancer
2016
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Understanding tumor ecosystems by single-cell sequencing: promises and limitations
2018
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
A view on drug resistance in cancer
2019 StandoutNature
Hepatocellular carcinoma
2016 Standout
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Precision oncology in the age of integrative genomics
2018
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Predicting treatment resistance and relapse through circulating DNA
2017
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
2016
Multiplex pairwise assembly of array-derived DNA oligonucleotides
2015 StandoutNobel
Liquid biopsy enters the clinic — implementation issues and future challenges
2021
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations
2016
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Challenges in circulating tumour cell research
2014
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Hepatocellular carcinoma
2021 Standout
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
2016
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
2016
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Recent advances in circulating nucleic acids in oncology
2019
Tumor metastasis: moving new biological insights into the clinic
2013
Colorectal cancer
2019 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Hepatocellular carcinoma: Mouse models and the potential roles of proteases
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
2014
Multimodal biomedical AI
2022 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Circulating miRNAs as Biomarker in Cancer
2019
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Emerging Biological Principles of Metastasis
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Oxidative Stress in Cancer
2020 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
2019
Tumours associated with BAP1 mutations
2012
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Bias in Whole Genome Amplification: Causes and Considerations
2015
Integrated digital error suppression for improved detection of circulating tumor DNA
2016
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
2016
Targeting TGF-β Signaling in Cancer
2017
The biology of circulating tumor cells
2015
Clinical applications of the CellSearch platform in cancer patients
2018
Origins, structures, and functions of circulating DNA in oncology
2016
Circulating tumor cells and CDX models as a tool for preclinical drug development
2017
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
2019
Technologies for detection of circulating tumor cells: facts and vision
2013
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
BAP1 and cancer
2013
Artificial intelligence in healthcare
2018 Standout
The first five years of single-cell cancer genomics and beyond
2015
Selection and adaptation during metastatic cancer progression
2013 Nature
Characterization of background noise in capture-based targeted sequencing data
2017
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Advances and Applications of Single-Cell Sequencing Technologies
2015
Biology, vulnerabilities and clinical applications of circulating tumour cells
2022
Hepatocellular carcinoma
2022 Standout
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Nucleic Acid Extraction and Sequencing from Low-Biomass Synthetic Mars Analog Soils for In Situ Life Detection
2019 StandoutNobel
Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
2020
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
2012
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
2015
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
The gate to metastasis: key players in cancer cell intravasation
2021
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis
2020
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer
2020
Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
2014
Progress and prospects of early detection in lung cancer
2017
A High-Plex PCR Approach for Massively Parallel Sequencing
2013
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
2015
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Circulating Tumor DNA as Biomarkers for Cancer Detection
2017
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
2013
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
2017
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing
2018
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)
2019
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemia
2015
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
2015
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)
2022 Standout
Works of Peter Ulz being referenced
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
2013
Circulating Tumor DNA as a Liquid Biopsy for Cancer
2014
Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
2014
The dynamic range of circulating tumor DNA in metastatic breast cancer
2014
Circulating tumor cells and DNA as liquid biopsies
2013
Evolution of Genomic Instability in Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice Δ
2010
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA
2016
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
2013
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
2016
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
2012
Inferring expressed genes by whole-genome sequencing of plasma DNA
2016
Non‐invasive detection of genome‐wide somatic copy number alterations by liquid biopsies
2015
Toward an Improved Definition of the Tumor Spectrum Associated With BAP1 Germline Mutations
2012
Combined Molecular Genetic and Cytogenetic Analysis from Single Cells after Isothermal Whole-Genome Amplification
2011
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
2015
Patient monitoring through liquid biopsies using circulating tumor DNA
2017